Public role in research oversight.
作者信息
Lipsitch Marc, Inglesby Thomas V, Cicero Anita, Relman David A
机构信息
Departments of Epidemiology and Immunology and Infectious Diseases, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Center for Health Security, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
出版信息
J Virol. 2024 Apr 16;98(4):e0006124. doi: 10.1128/jvi.00061-24. Epub 2024 Mar 13.
Abstract
摘要
相似文献
1
Public role in research oversight.
J Virol. 2024 Apr 16;98(4):e0006124. doi: 10.1128/jvi.00061-24. Epub 2024 Mar 13.
2
Implementing governmental oversight of enhanced potential pandemic pathogen research.
J Virol. 2024 Apr 16;98(4):e0023724. doi: 10.1128/jvi.00237-24. Epub 2024 Mar 13.
3
Reply to Ebright et al., "Implementing governmental oversight of enhanced potential pandemic pathogen research".
J Virol. 2024 Apr 16;98(4):e0025624. doi: 10.1128/jvi.00256-24. Epub 2024 Mar 13.
4
Containing risk.
Nature. 2009 Oct 1;461(7264):569-70. doi: 10.1038/461569b.
5
The new Brazilian legislation on access to the biodiversity (Law 13,123/15 and Decree 8772/16).
Braz J Microbiol. 2018 Jan-Mar;49(1):1-4. doi: 10.1016/j.bjm.2017.12.001.
6
Biosecurity. Lawmakers signal tougher controls on pathogen research.
Science. 2009 Oct 2;326(5949):28-9. doi: 10.1126/science.326_28b.
7
Biodefense. Senate bill would alter biosafety, select agent rules.
Science. 2008 Jun 20;320(5883):1573. doi: 10.1126/science.320.5883.1573.
8
New rules for biosecurity.
Science. 2009 May 29;324(5931):1117. doi: 10.1126/science.1176543.
9
In search of biosecurity.
Science. 2006 Mar 31;311(5769):1835. doi: 10.1126/science.1127725.
10
Booming biosafety labs probed.
Nature. 2009 Oct 1;461(7264):577. doi: 10.1038/461577a.
引用本文的文献
1
Principal Investigator Responsibility for Flagging Research with Dual-Use or Pandemic Risk.
Appl Biosaf. 2025 Jun 5;30(2):139-142. doi: 10.1089/apb.2024.0059. eCollection 2025 Jun.
本文引用的文献
1
Correction for Rasmussen et al., "Virology-the path forward".
J Virol. 2024 Mar 19;98(3):e0007424. doi: 10.1128/jvi.00074-24. Epub 2024 Feb 9.
2
Virology-the path forward.
J Virol. 2024 Jan 23;98(1):e0179123. doi: 10.1128/jvi.01791-23. Epub 2024 Jan 3.
3
The Epistemic Value of Gain of Function Experiments.
mSphere. 2024 Jan 30;9(1):e0071423. doi: 10.1128/msphere.00714-23. Epub 2023 Dec 22.
4
Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined.
J Virol. 2023 Mar 30;97(3):e0017623. doi: 10.1128/jvi.00176-23. Epub 2023 Feb 27.
5
Virology under the Microscope-a Call for Rational Discourse.
mSphere. 2023 Apr 20;8(2):e0003423. doi: 10.1128/msphere.00034-23. Epub 2023 Jan 26.
6
Virology in Peril and the Greater Risk To Science.
mSphere. 2023 Feb 21;8(1):e0060722. doi: 10.1128/msphere.00607-22. Epub 2022 Dec 15.
7
Strengthen oversight of risky research on pathogens.
Science. 2022 Dec 16;378(6625):1170-1172. doi: 10.1126/science.adf6020. Epub 2022 Dec 8.
8
Why Do Exceptionally Dangerous Gain-of-Function Experiments in Influenza?
Methods Mol Biol. 2018;1836:589-608. doi: 10.1007/978-1-4939-8678-1_29.
9
SCIENCE GOVERNANCE. A more systematic approach to biological risk.
Science. 2015 Dec 18;350(6267):1471-3. doi: 10.1126/science.aad8849.
10
The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.
J Med Ethics. 2015 Nov;41(11):901-8. doi: 10.1136/medethics-2014-102619. Epub 2015 Aug 28.
Zotero 插件